The results showed that icariin could reduce ROS, MMP, and apoptosis levels and increase PI3K and p‐AKT levels in adriamycin‐induced NRK‐52e cells, suggesting that icariin may be the active ingredient of EPI in the treatment of adriamycin‐induced nephropathy. The gene discussed is AKT1; the disease is Nephropathy.